Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it is entering into its seventh strategic ...
The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...
BillionToOne, Inc. , a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the selection of Northstar Select® ...
Notable assay results include silver values up to 2,370 g/t Ag , lead exceeding 20% Pb , zinc values up to 19.25% Zn , ...
26m
Walz, Democrats' 2024 VP Pick, Drops Bid for Third Term as Minnesota Governor; Klobuchar Considers
Minnesota Gov. Tim Walz is ending his bid for a third term amid President Donald Trump’s relentless focus on a fraud ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...
Autolus Therapeutics plc , a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first Integrated ...
Autolus will evaluate Cellares' fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback